Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System

Rhea-AI Summary

Izotropic Corporation (OTCQB: IZOZF) announced placement in an editorial published by NetworkNewsWire on Oct 22, 2025, highlighting AI-enabled breast imaging and a projected $9 billion market for next‑gen 3D AI-imaging technologies.

The piece frames AI as a tool to improve early breast cancer detection and cites global statistics: 2.3 million diagnoses and ~670,000 deaths in 2022 (WHO) and 316,950 new invasive U.S. cases projected this year (ACS). The editorial spotlights Izotropic's IzoView Breast CT Imaging System, a dedicated 3D platform aimed at better detection for women with dense breast tissue.

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community.

To view the full publication, “Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market,” please visit: https://nnw.fm/ggXBU

Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer detection, where early diagnosis can mean the difference between life and death, AI-enhanced modalities present a chance to leap beyond the limits of mammography, tomosynthesis and MRI. Globally, breast cancer remains one of the most common cancers in women. According to the World Health Organization (WHO), more than 2.3 million women were diagnosed with breast cancer in 2022, and approximately 670,000 women died from the disease globally. In the United States, the American Cancer Society (ACS) projects that 316,950 new invasive breast cancer cases will be diagnosed among women this year.

The urgent, life-saving need for earlier and more accurate detection creates a powerful opportunity for innovation in diagnostic imaging. Amid this global challenge, companies advancing breast cancer diagnostics are entering a high-impact field. Among them, Izotropic Corporation stands out with its next-generation IzoView Breast CT Imaging System, a dedicated 3D imaging platform designed to improve detection accuracy, particularly for women with dense breast tissue.

About Izotropic Corporation

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) is a medical device company commercializing innovative, emerging technologies and imaging-based products for the more accurate screening, diagnoses and treatment of breast cancers

More information about Izotropic can be found on its website at IzoCorp.com 

NOTE TO INVESTORS: The latest news and updates relating to IZOZF are available in the company’s newsroom at https://ibn.fm/IZOZF

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: https://www.NetworkNewsWire.com/Disclaimer

NetworkNewsWire
New York, NY
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is powered by IBN

FAQ

What did Izotropic (IZOZF) announce on Oct 22, 2025?

Izotropic announced placement in a NetworkNewsWire editorial highlighting AI breast imaging and its IzoView Breast CT Imaging System.

What is the market size mentioned for next‑gen 3D AI-imaging in the Oct 22, 2025 editorial?

The editorial cites a projected $9 billion market for next‑gen 3D AI-imaging technologies.

How does the Oct 22, 2025 announcement describe IzoView Breast CT for IZOZF investors?

It describes IzoView as a dedicated 3D breast CT platform designed to improve detection accuracy, especially for women with dense breast tissue.

What health statistics were cited in the Oct 22, 2025 Izotropic editorial?

Cited figures include 2.3 million global breast cancer diagnoses and ~670,000 deaths in 2022 (WHO) and 316,950 new invasive U.S. cases projected this year (ACS).

Where can investors read the Oct 22, 2025 editorial about Izotropic (IZOZF)?

The editorial was published via NetworkNewsWire; the announcement included a link to the full publication.